Advertisement
Screener

Anika Therapeutics, Inc. (ANIK) Operating Cash Flow

2.8 / 5 stars · 68/120 Roast Me

Anika Therapeutics, Inc. Operating Cash Flow

Anika Therapeutics, Inc. (ANIK) reported Operating Cash Flow of -$5.53 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.

Financial Statements › Cash Flow › Operating Activities

us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-07-29

  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$684.00K.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$4.85M.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-12-31 was $4.64M, a 193.11% increase year-over-year.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-09-30 was $6.87M, a 36.96% increase year-over-year.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2025 was $11.19M, a 107.07% increase from fiscal 2024.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2024 was $5.40M.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2023 was -$1.79M, a 140.55% decline from fiscal 2022.
  • Anika Therapeutics, Inc. net cash provided by (used in) operating activities for fiscal 2022 was $4.41M, a 47.49% decline from fiscal 2021.
Period endNet Cash Provided by (Used in) Operating Activities 3 monthNet Cash Provided by (Used in) Operating Activities 3 month as first filedNet Cash Provided by (Used in) Operating Activities 6 monthNet Cash Provided by (Used in) Operating Activities 6 month as first filedNet Cash Provided by (Used in) Operating Activities 9 monthNet Cash Provided by (Used in) Operating Activities 9 month as first filedNet Cash Provided by (Used in) Operating Activities 12 monthNet Cash Provided by (Used in) Operating Activities 12 month as first filed
2026-06-30-$684.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
-$5.53M
10-Q · filed 2026-07-29
-$893.00K
derived: sum of 3 quarters · filed 2026-07-29
$5.98M
derived: sum of 4 quarters · filed 2026-07-29
2026-03-31-$4.85M
10-Q · filed 2026-04-30
-$209.00K
derived: sum of 2 quarters · filed 2026-04-30
$6.66M
derived: sum of 3 quarters · filed 2026-04-30
$6.47M
derived: sum of 4 quarters · filed 2026-07-29
2025-12-31$4.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03
$11.51M
derived: sum of 2 quarters · filed 2026-03-03
$11.32M
derived: sum of 3 quarters · filed 2026-07-29
$11.19M
10-K · filed 2026-03-03
2025-09-30$6.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$6.68M
derived: sum of 2 quarters · filed 2026-07-29
$6.55M
10-Q · filed 2025-11-05
$8.13M
derived: sum of 4 quarters · filed 2026-07-29
2025-06-30-$189.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29
-$319.00K
10-Q · filed 2026-07-29
$1.26M
derived: sum of 3 quarters · filed 2026-07-29
$6.28M
derived: sum of 4 quarters · filed 2026-07-29
2025-03-31-$130.00K
10-Q · filed 2026-04-30
$1.45M
derived: sum of 2 quarters · filed 2026-04-30
$6.47M
derived: sum of 3 quarters · filed 2026-04-30
$5.40M
derived: sum of 4 quarters · filed 2026-04-30
2024-12-31$1.58M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03
$6.60M
derived: sum of 2 quarters · filed 2026-03-03
$5.53M
derived: sum of 3 quarters · filed 2026-03-03
$5.40M
10-K · filed 2026-03-03
2024-09-30$5.02M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
$3.95M
derived: sum of 2 quarters · filed 2025-11-05
$3.82M
10-Q · filed 2025-11-05
$7.46M
derived: sum of 4 quarters · filed 2026-03-03
2024-06-30-$1.07M
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-30
-$1.20M
10-Q · filed 2025-07-30
$2.44M
derived: sum of 3 quarters · filed 2026-03-03
$8.93M
derived: sum of 4 quarters · filed 2026-03-03
2024-03-31-$126.00K
10-Q · filed 2025-05-09
$3.51M
derived: sum of 2 quarters · filed 2026-03-03
$10.00M
derived: sum of 3 quarters · filed 2026-03-03
$1.70M
derived: sum of 4 quarters · filed 2026-03-03
2023-12-31$3.64M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03
$10.12M
derived: sum of 2 quarters · filed 2026-03-03
$1.83M
derived: sum of 3 quarters · filed 2026-03-03
-$1.79M
10-K · filed 2026-03-03
2023-09-30$6.49M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-04
-$1.81M
derived: sum of 2 quarters · filed 2024-11-04
-$5.43M
10-Q · filed 2024-11-04
-$4.95M
derived: sum of 4 quarters · filed 2025-03-17
2023-06-30-$8.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$11.91M
10-Q · filed 2024-08-08
-$11.43M
derived: sum of 3 quarters · filed 2025-03-17
-$8.72M
derived: sum of 4 quarters · filed 2025-03-17
2023-03-31-$3.62M
10-Q · filed 2024-05-08
-$3.14M
derived: sum of 2 quarters · filed 2025-03-17
-$428.00K
derived: sum of 3 quarters · filed 2025-03-17
$2.66M
derived: sum of 4 quarters · filed 2025-03-17
2022-12-31$481.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-17
$3.19M
derived: sum of 2 quarters · filed 2025-03-17
$6.28M
derived: sum of 3 quarters · filed 2025-03-17
$4.41M
10-K · filed 2025-03-17
2022-09-30$2.71M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$5.80M
derived: sum of 2 quarters · filed 2023-11-03
$3.93M
10-Q · filed 2023-11-03
$8.40M
derived: sum of 4 quarters · filed 2024-03-15
2022-06-30$3.09M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08
$1.22M
10-Q · filed 2023-08-08
$5.69M
derived: sum of 3 quarters · filed 2024-03-15
$7.75M
derived: sum of 4 quarters · filed 2024-03-15
2022-03-31-$1.87M
10-Q · filed 2023-05-09
$2.60M
derived: sum of 2 quarters · filed 2024-03-15
$4.67M
derived: sum of 3 quarters · filed 2024-03-15
$8.96M
derived: sum of 4 quarters · filed 2024-03-15
2021-12-31$4.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-15
$6.53M
derived: sum of 2 quarters · filed 2024-03-15
$10.83M
derived: sum of 3 quarters · filed 2024-03-15
$8.40M
10-K · filed 2024-03-15
2021-09-30$2.06M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09
$6.36M
derived: sum of 2 quarters · filed 2022-11-09
$3.92M
10-Q · filed 2022-11-09
$6.51M
derived: sum of 4 quarters · filed 2023-03-16
2021-06-30$4.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04
$1.86M
10-Q · filed 2022-08-04
$4.45M
derived: sum of 3 quarters · filed 2023-03-16
$10.31M
derived: sum of 4 quarters · filed 2023-03-16
2021-03-31-$2.43M
10-Q · filed 2022-05-06
$156.00K
derived: sum of 2 quarters · filed 2023-03-16
$6.02M
derived: sum of 3 quarters · filed 2023-03-16
$9.59M
derived: sum of 4 quarters · filed 2023-03-16
2020-12-31$2.59M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16
$8.45M
derived: sum of 2 quarters · filed 2023-03-16
$12.02M
derived: sum of 3 quarters · filed 2023-03-16
$13.06M
10-K · filed 2023-03-16
2020-09-30$5.87M
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
$9.43M
derived: sum of 2 quarters · filed 2021-11-05
$10.48M
10-Q · filed 2021-11-05
$23.50M
derived: sum of 4 quarters · filed 2022-03-11
2020-06-30$3.57M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
$4.61M
10-Q · filed 2021-08-06
$17.64M
derived: sum of 3 quarters · filed 2022-03-11
$27.69M
derived: sum of 4 quarters · filed 2022-03-11
2020-03-31$1.04M
10-Q · filed 2021-05-07
$14.07M
derived: sum of 2 quarters · filed 2022-03-11
$24.12M
derived: sum of 3 quarters · filed 2022-03-11
$29.59M
derived: sum of 4 quarters · filed 2022-03-11
2019-12-31$13.02M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11
$23.07M
derived: sum of 2 quarters · filed 2022-03-11
$28.54M
derived: sum of 3 quarters · filed 2022-03-11
$37.01M
10-K · filed 2022-03-11
2019-09-30$10.05M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05
$15.52M
derived: sum of 2 quarters · filed 2020-11-05
$23.98M
10-Q · filed 2020-11-05
$34.00M
derived: sum of 4 quarters · filed 2021-04-26
2019-06-30$5.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07
$13.93M
10-Q · filed 2020-08-07
$23.95M
derived: sum of 3 quarters · filed 2021-04-26
$34.79M
derived: sum of 4 quarters · filed 2021-04-26
2019-03-31$8.46M
10-Q · filed 2020-05-22
$18.48M
derived: sum of 2 quarters · filed 2021-04-26
$29.32M
derived: sum of 3 quarters · filed 2021-04-26
$33.79M
derived: sum of 4 quarters · filed 2021-04-26
2018-12-31$10.01M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2021-04-26
$20.86M
derived: sum of 2 quarters · filed 2021-04-26
$25.33M
derived: sum of 3 quarters · filed 2021-04-26
$34.92M
10-K/A · filed 2021-04-26
2018-09-30$10.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-28
$15.31M
derived: sum of 2 quarters · filed 2019-10-28
$24.91M
10-Q · filed 2019-10-28
$31.89M
derived: sum of 4 quarters · filed 2020-03-06
2018-06-30$4.47M
derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-26
$14.06M
10-Q · filed 2019-07-26
$21.04M
derived: sum of 3 quarters · filed 2020-03-06
$33.14M
derived: sum of 4 quarters · filed 2020-03-06
2018-03-31$9.59M
10-Q · filed 2019-05-06
$16.57M
derived: sum of 2 quarters · filed 2020-03-06
$28.67M
derived: sum of 3 quarters · filed 2020-03-06
$34.94M
derived: sum of 4 quarters · filed 2020-03-06
2017-12-31$6.98M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06
$19.08M
derived: sum of 2 quarters · filed 2020-03-06
$25.35M
derived: sum of 3 quarters · filed 2020-03-06
$40.81M
10-K · filed 2020-03-06
2017-09-30$12.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-26
$18.37M
derived: sum of 2 quarters · filed 2018-10-26
$33.83M
10-Q · filed 2018-10-26
$39.90M
derived: sum of 4 quarters · filed 2019-02-27
2017-06-30$6.27M
derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-31
$21.73M
10-Q · filed 2018-07-31
$27.80M
derived: sum of 3 quarters · filed 2019-02-27
$39.54M
derived: sum of 4 quarters · filed 2019-02-27
2017-03-31$15.46M
10-Q · filed 2018-05-10
$21.53M
derived: sum of 2 quarters · filed 2019-02-27
$33.27M
derived: sum of 3 quarters · filed 2019-02-27
$31.86M
derived: sum of 4 quarters · filed 2019-02-27
2016-12-31$6.07M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27
$17.80M
derived: sum of 2 quarters · filed 2019-02-27
$16.40M
derived: sum of 3 quarters · filed 2019-02-27
$24.45M
10-K · filed 2019-02-27
$23.80M
10-K · filed 2017-02-24
2016-09-30$11.73M
derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-27
$10.33M
derived: sum of 2 quarters · filed 2017-10-27
$18.38M
10-Q · filed 2017-10-27
$17.96M
10-Q · filed 2016-11-01
$34.50M
derived: sum of 4 quarters · filed 2018-02-27
2016-06-30-$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01
$6.64M
10-Q · filed 2016-08-01
$22.76M
derived: sum of 3 quarters · filed 2018-02-27
$31.67M
derived: sum of 4 quarters · filed 2018-02-27
2016-03-31$8.04M
10-Q · filed 2017-05-04
$7.68M
10-Q · filed 2016-05-03
$24.16M
derived: sum of 2 quarters · filed 2018-02-27
$33.07M
derived: sum of 3 quarters · filed 2018-02-27
$43.97M
derived: sum of 4 quarters · filed 2018-02-27
2015-12-31$16.12M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27
$25.03M
derived: sum of 2 quarters · filed 2018-02-27
$35.93M
derived: sum of 3 quarters · filed 2018-02-27
$39.91M
10-K · filed 2018-02-27
$39.06M
10-K · filed 2016-03-10
2015-09-30$8.91M
derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-01
$19.81M
derived: sum of 2 quarters · filed 2016-11-01
$23.79M
10-Q · filed 2016-11-01
$23.79M
10-Q · filed 2015-11-03
$38.55M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$10.90M
derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-01
$14.88M
10-Q · filed 2016-08-01
$14.88M
10-Q · filed 2015-08-04
$29.64M
derived: sum of 3 quarters · filed 2017-02-24
$37.03M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$3.98M
10-Q · filed 2016-05-03
$3.98M
10-Q · filed 2015-05-04
$18.74M
derived: sum of 2 quarters · filed 2017-02-24
$26.13M
derived: sum of 3 quarters · filed 2017-02-24
$30.37M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$14.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$22.14M
derived: sum of 2 quarters · filed 2017-02-24
$26.38M
derived: sum of 3 quarters · filed 2017-02-24
$39.98M
10-K · filed 2017-02-24
2014-09-30$7.39M
derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03
$11.63M
derived: sum of 2 quarters · filed 2015-11-03
$25.22M
10-Q · filed 2015-11-03
$33.23M
derived: sum of 4 quarters · filed 2016-03-10
2014-06-30$4.24M
derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04
$17.84M
10-Q · filed 2015-08-04
$20.32M
10-Q · filed 2014-08-04
$25.84M
derived: sum of 3 quarters · filed 2016-03-10
$33.37M
derived: sum of 4 quarters · filed 2016-03-10
2014-03-31$13.60M
10-Q · filed 2015-05-04
$21.60M
derived: sum of 2 quarters · filed 2016-03-10
$29.13M
derived: sum of 3 quarters · filed 2016-03-10
$32.69M
derived: sum of 4 quarters · filed 2016-03-10
2013-12-31$8.01M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-10
$15.53M
derived: sum of 2 quarters · filed 2016-03-10
$19.10M
derived: sum of 3 quarters · filed 2016-03-10
$25.16M
10-K · filed 2016-03-10
$25.17M
10-K · filed 2014-03-13
2013-09-30$7.53M
derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06
$11.09M
derived: sum of 2 quarters · filed 2014-11-06
$17.16M
10-Q · filed 2014-11-06
$21.97M
derived: sum of 4 quarters · filed 2014-11-06
2013-06-30$3.56M
derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04
$9.63M
10-Q · filed 2014-08-04
$14.45M
derived: sum of 3 quarters · filed 2014-08-04
$16.65M
derived: sum of 4 quarters · filed 2014-08-04
2013-03-31$6.07M
10-Q · filed 2014-05-05
$10.88M
derived: sum of 2 quarters · filed 2014-05-05
$13.08M
derived: sum of 3 quarters · filed 2014-05-05
$18.31M
derived: sum of 4 quarters · filed 2014-05-05
2012-12-31$4.81M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$7.01M
derived: sum of 2 quarters · filed 2014-03-13
$12.24M
derived: sum of 3 quarters · filed 2014-03-13
$10.55M
10-K · filed 2014-03-13
2012-09-30$2.20M
derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-05
$7.43M
derived: sum of 2 quarters · filed 2013-11-05
$5.74M
10-Q · filed 2013-11-05
$13.04M
derived: sum of 4 quarters · filed 2014-03-13
2012-06-30$5.22M
derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06
$3.53M
10-Q · filed 2013-08-06
$10.84M
derived: sum of 3 quarters · filed 2014-03-13
$13.82M
derived: sum of 4 quarters · filed 2014-03-13
2012-03-31-$1.69M
10-Q · filed 2013-05-06
$5.62M
derived: sum of 2 quarters · filed 2014-03-13
$8.59M
derived: sum of 3 quarters · filed 2014-03-13
$7.20M
derived: sum of 4 quarters · filed 2014-03-13
2011-12-31$7.31M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-13
$10.28M
derived: sum of 2 quarters · filed 2014-03-13
$8.89M
derived: sum of 3 quarters · filed 2014-03-13
$10.17M
10-K · filed 2014-03-13
2011-09-30$2.98M
derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08
$1.58M
derived: sum of 2 quarters · filed 2012-11-08
$2.87M
10-Q · filed 2012-11-08
$6.63M
derived: sum of 4 quarters · filed 2013-03-14
2011-06-30-$1.40M
derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07
-$110.50K
10-Q · filed 2012-08-07
$3.66M
derived: sum of 3 quarters · filed 2013-03-14
$6.96M
derived: sum of 4 quarters · filed 2013-03-14
2011-03-31$1.29M
10-Q · filed 2012-05-07
$5.06M
derived: sum of 2 quarters · filed 2013-03-14
$8.36M
derived: sum of 3 quarters · filed 2013-03-14
2010-12-31$3.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-14
$7.07M
derived: sum of 2 quarters · filed 2013-03-14
$7.85M
10-K · filed 2013-03-14
2010-09-30$3.31M
derived: 10-Q 9 month − 10-Q/A 6 month · filed 2011-11-04
$4.08M
10-Q · filed 2011-11-04
2010-06-30$779.34K
10-Q/A · filed 2011-08-10
2009-12-31$3.09M
10-K · filed 2012-03-13

Similar stocks

Stock NameCountryMarket CapPE Ratio
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
Mobia Medical, Inc. (MOBI)United States$0.293B
TREACE MEDICAL CONCEPTS, INC. (TMCI)United States$0.297B-4.32
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
PRO DEX INC (PDEX)United States$0.234B13.64
Embecta Corp. (EMBC)United States$0.319B2.10
Neuronetics, Inc. (STIM)United States$0.216B-3.25